The Chairman of the Pharmaceutical Authority receives the delegation of the Holding Company for the vaccines «Faxira»
Dr. Ali Al -Ghamrawi, Chairman of the Egyptian Pharmaceutical Authority, received the delegation of the Holding Company for Divide & Laquo; Faxira & Raquo; Headed by Dr. Sharif Al -Fil, Chairman of the company’s board of directors, to discuss a number of technical and organizational issues related to preparations presented by the company.
& nbsp; The vaccines and the opening of new export markets. The appropriate organizational environment that contributes to upgrading the quality of the pharmaceutical industries in Egypt, while preserving the highest standards of safety, efficiency and transparency. The resettlement of the industry, indicating that the Egyptian state facilitates the procedures for all the rules for registration of innovative drugs, and setting applied solutions to the challenges facing those who wish to manufacture the drug locally. Asma Fouad, Head of the Central Administration for Biological and Innovative Prospects and Clinical Studies, and Dr. Amira Mahjoub, head of the Central Operations Department, and from the side of the Holding Company for Divide & Laquo; Faxra & RAKUO; D. Irene Fouad, CEO of the company, Dr. Hiba Ali, Head of the Operations Sector of the company, and Dr. Hana Omar, Director of the Technical Office of the Chairman of the Company’s Board of Directors.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Related
